Eli Lilly and Company (NYSE:LLY) will release earnings results for the second quarter before the opening bell on Thursday, ...

Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

Eli Lilly is investing up to $4 billion in the Bristol project and Wisconsin plans to provide up to $100 million in ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...

Eli Lilly and Company (LLY), headquartered in Indianapolis, Indiana, is a major American pharmaceutical company. Established ...

While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

BRANCHBURG – Eli Lilly, a multinational pharmaceutical company headquartered in Indianapolis with $45 billion in annual sales, has confirmed that it is selling its facility on Imclone Lane off Route ...

Wisconsin is set to give Eli Lilly up to $100 million in Enterprise Zone tax credits for its $3 billion expansion in Bristol ...

Under the terms of the agreement, Eli Lilly is to make double-digit million-dollar upfront payments and invest in LTZ’s equity. In addition, LTZ is entitled to receive preclinical, clinical, ...

Eli Lilly and Company, a pharmaceutical manufacturing facility, will be receiving up to $100 million in performance-based state tax credits for its $4 billion investment in Wisconsin.